1. Introduction {#sec1}
===============

The stable reactive oxygen species (ROS) hydrogen peroxide (H~2~O~2~) plays essential roles in endothelial cell biology, including endothelium-regulated vasorelaxation and vascular remodeling \[[@bib1], [@bib2], [@bib3], [@bib4]\]. Higher concentrations of ROS can cause pathological oxidative stress in the vasculature, but lower concentration of H~2~O~2~ play important roles in cellular signal transduction. H~2~O~2~ is differentially localized in subcellular organelles, yet little is known of the consequences of H~2~O~2~ localization on cellular signaling responses \[[@bib5], [@bib6], [@bib7]\]. H~2~O~2~ is generated in diverse pathways that are themselves differentially distributed within cells \[[@bib2],[@bib5], [@bib6], [@bib7], [@bib8]\], including membrane-targeted NADPH oxidases (NOXs), uncoupled nitric oxide synthases, xanthine oxidases, and components of the mitochondrial electron transport chain. Degradation of H~2~O~2~ is catalyzed by a broad range of oxidoreductases that also are localized in specific subcellular compartments \[[@bib5],[@bib8]\]. The downstream targets of H~2~O~2~ include a broad range of differentially-targeted protein kinases, phosphoprotein phosphatases, and oxidant-modulated transcription factors. H~2~O~2~ also modulates cellular signaling pathways by the dynamic oxidation of specific enzymatic substrates and cofactors. Thus, the differential redox state of specific subcellular locales can significantly affect oxidant-dependent signaling responses in cells \[[@bib5],[@bib9]\]. In vascular endothelial cells, H~2~O~2~ regulates phosphorylation pathways that modulate the endothelial nitric oxide synthase (eNOS), a redox-modulated enzyme that generates nitric oxide (NO), a critical determinant of vascular homeostasis \[[@bib4]\]. eNOS is dynamically targeted to plasmalemmal caveolae in endothelial cells, and the differential agonist-modulated localization of eNOS affects its role in cell signaling \[[@bib10]\]. Two key signaling regulated by H~2~O~2~ that have been implicated in the modulation of eNOS phosphorylation in endothelial cells are kinase Akt (also known as protein kinase B) and the AMP-associated kinase (AMPK), both of which are phosphoproteins that also undergo dynamic subcellular translocation within cells \[[@bib1],[@bib11], [@bib12], [@bib13]\].

For many years, the biological roles of H~2~O~2~ were studied principally simply by adding exogenous H~2~O~2~ to cultured cells or isolated tissues and then measuring one physiological or biochemical response or another. However, the addition of exogenous H~2~O~2~ to cultured cells does not replicate the more selective spatiotemporal pattern of intracellular endogenous H~2~O~2~ flux in the regulation of signaling responses \[[@bib7],[@bib14],[@bib15]\]. With this increased appreciation for the intracellular roles of endogenous H~2~O~2~ as a second messenger, we developed a chemogenetic approach that dynamically modulates H~2~O~2~ levels in specific subcellular organelles in cultured endothelial cells.

The term "chemogenetics" is used to describe experimental systems in which the activity of a protein can be dynamically regulated inside a cell by providing or withholding the protein\'s biochemical stimulus. We recently developed and validated chemogenetic approaches to manipulate H~2~O~2~ levels in specific subcellular locales using differentially-targeted yeast [d]{.smallcaps}-amino acid oxidase (DAAO) constructs. Yeast DAAO is a stereospecific enzyme that generates hydrogen peroxide (H~2~O~2~) only when [d]{.smallcaps}-amino acids are provided as substrate \[[@bib16]\]. Since most mammalian tissues contain only [l]{.smallcaps}-amino acids, the yeast DAAO is inactive until [d]{.smallcaps}-amino acids are made available \[[@bib14],[@bib16]\]. We constructed a fusion protein between DAAO and the H~2~O~2~ biosensor HyPer7.2 to allow the simultaneous quantitation (HyPer) and generation (DAAO) of H~2~O~2~. The new HyPer7.2 ratiometric biosensor is much more sensitive than earlier generations of the HyPer biosensor, and permits the quantitation of intracellular H~2~O~2~ levels in specific subcellular locales after adding extracellular H~2~O~2~ to the cells in culture. In these studies, we report experiments performed using the human endothelial cell line EA.hy926, which has been extensively studied from the standpoint of endothelial signaling \[[@bib4],[@bib17]\]. As we show below, there is a marked discordance in the biochemical responses to extracellular H~2~O~2~ *vs.* intracellular (chemogenetic) H~2~O~2~ in the modulation of phosphorylation pathways in endothelial cells.

2. Materials and methods {#sec2}
========================

***Reagents:*** Fetal bovine serum (FBS) was purchased from HyClone (Logan, UT); all other cell culture reagents and media were from Invitrogen. The PI3--K inhibitor wortmannin and AMPK inhibitor Compound C were from Calbiochem. Polyclonal antibodies against phospho-eNOS Ser-1177 and Thr-495, phospho-Akt Ser-473, Akt, phospho-AMPK Thr-172, AMPK, phospho-ACC Ser-79 and ACC, as well as total eNOS and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) monoclonal antibodies plus secondary antibodies conjugated with horseradish peroxidase were from Cell Signaling Technologies. Phospho-eNOS Ser-114 and Ser-633 monoclonal antibodies were from EMD-Millipore. Super Signal (Femto) chemiluminescence detection reagents were from Pierce Biotechnology. [d]{.smallcaps}-alanine, [l]{.smallcaps}-alanine, H2O2 and other reagents were from Sigma Aldrich. The immunoblotting reagents were from Bio-Rad and Boston Bioproducts.

***Cell culture:*** EA.hy926 human endothelial cells were obtained from ATCC (CRL-2922) and cultured in Dulbecco\'s modified Eagle\'s medium (DMEM) culture medium supplemented with 10% (v/v) fetal bovine serum (FBS) and 1% penicillin--streptomycin \[[@bib4]\]. The cells were studied at 60--70% confluence between passages 30 and 50.

***Plasmid and Adenovirus HyPer-DAAO fusion constructs:*** The generation and characterization of differentially-targeted HyPer1-DAAO constructs have been previously described in detail \[[@bib14]\]. We attached subcellular targeting signal sequences to the coding region of HyPer-DAAO to create constructs that are cytosol-targeted (using a nuclear exclusion sequence, termed NES); nucleus-targeted (nuclear localization sequence, termed NLS); or caveolae-targeting (CAV) sequences, as described \[[@bib14]\]. The PCR fragment was then ligated into the pC1-CMV vector. The constructs were generated by fusing the cDNA for HyPer1 with the DAAO-NES or -NLS or -Cav with a Gly-Gly-Ser-Gly linker between HyPer1 and DAAO using the NEBuilder HiFi DNA assembly system (New England Biolabs). The resulting fusion constructs were inserted into the adenovirus serotype 5 (AV5) expression vector between the EcoRI and *Hin*dIII restriction enzyme sites. Constructs were veriﬁed by whole plasmid sequencing and packaged into AV5 viral vectors by ViraQuest Inc, USA.

For imaging experiments, we used the novel ratiometric HyPer7.2 construct to generate a fusion construct composed of HyPer7.2 \[[@bib18]\] and DAAO, which were targeted using subcellular localization sequences as described above. In brief, the HyPer1 sequence from previously-characterized differentially-targeted HyPer-DAAO constructs were exchanged for HyPer7.2. The resulting differentially-targeted HyPer7.2-DAAO fusion constructs were then subcloned in a pCS2+ vector following excision of the original full-length insert using EcoRI and *Xho*I.

***Adenoviral transduction:*** The cells were transduced with adenovirus 5-HyPer-DAAO targeted to the cell cytosol, nucleus or caveolae at a multiplicity of infection of 1000 in serum-free culture media; 5 h later, the media was exchanged for fresh media containing 10% FBS 5h. All cell treatments and experiments were performed 48 h after adenoviral transduction.

***Plasmid transfection:*** EA.hy926 cells at \~70% confluence were transfected with 1 μg plasmid DNA encoding HyPer7.2-DAAO targeted to the cell cytosol, nucleus or caveolae \[[@bib14]\] in serum-free culture medium, using the transfection reagent PolyJet according to the manufacturer\'s instructions (SignaGen Laboratories). After 5h incubation, the media was exchanged for fresh media containing 10% FBS. All treatments and experiments were performed 16--24 h after transfection.

***Intracellular H***~***2***~***O***~***2***~ ***detection by HyPer7.2 imaging:*** EA.hy926 endothelial cells expressing HyPer7.2-DAAO targeted to specific subcellular locales were treated with [d]{.smallcaps}-alanine or H~2~O~2~ 48 h after transfection, and were then imaged in real time as previously described in detail \[[@bib16],[@bib18]\]. In brief, cells were first washed with PBS and incubated for at least 2 h in a HEPES-buffered solution containing using a custom perfusion system with a peristaltic pump to maintain stable superfusion conditions. The superfusion solution consists of a physiological buffer with the following composition: 140 mM NaCl, 5 mM KCl, 2 mM CaCl~2~, 1 mM MgCl~2~, 10 mM [d]{.smallcaps}-glucose and 1 mM HEPES, pH 7.4. For live-cell fluorescence imaging, the ratiometric HyPer7.2 biosensor was excited at 420 nm and 490 nm, and emission was collected at 530 nm. Detailed imaging protocols using HyPer7.2 have been previously reported \[[@bib18]\]. The HyPer7.2 ratio was visualized with a 40X oil immersion objective (Olympus). Images were acquired using a CCD camera (Hammamatsu) and analyzed by Metafluor Software (Molecular Devices). Following equal background subtraction of the emissions at both wavelengths, ratiometric HyPer7.2 signals were defined as a ratio of the intensities of the emission signals excited by 490 nm or 420 nm and normalized through R0. Ratiometric images of [Fig. 3](#fig3){ref-type="fig"} are displayed in a color lookup table in which the color corresponds to the HyPer1 ratio of AV5-HyPer1DAAO transduced cells.

***Cell treatment and immunoblotting:*** 48 h after viral infection, EA.hy926 cells transduced by differentially-targeted AV5- HyPer-DAAO were incubated with D- or [l]{.smallcaps}-alanine (10 mM) or vehicle (H2O). Wortmannin and Compound C were dissolved in dimethyl sulfoxide (DMSO) and used to treat the cells for 30 min before adding [d]{.smallcaps}-alanine or H~2~O~2~. Where indicated, water or DMSO 0.1% (v/v) were used as control. After drug treatments, the cells were washed twice with ice-cold PBS and lysed using the cell radioimmunoprecipitation assay (RIPA) lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% NP-40, 0.25% sodium deoxycholate, 0.1% SDS, 1 mM EDTA, 2 mM Na3VO4, 10 mM NaF, 2 μg/ml leupeptin, 2 μg/ml antipain, 2 μg/ml soybean trypsin inhibitor, and 2 μg/ml lima trypsin inhibitor). Cell lysates were prepared, resolved by electrophoresis on 10% SDS-polyacrylamide gels and transferred to a nitrocellulose membrane. Immunoblot analyses of protein expression and phosphorylation were probed using phosphospecific primary antibodies (1:1000) as indicated. The membranes were then incubated with a horseradish peroxidase-labeled anti-rabbit or anti-mouse immunoglobulin G secondary antibody (1:2000). The membranes were then re-blotted with total eNOS, Akt, AMPK and ACC antibodies (1:1000) as loading controls. Immunoblots were analyzed by chemiluminescence using a ChemiImager HD4000 (Alpha Innotech, San Leandro, CA) and quantitative densitometric analyses were performed using ImageJ software (NIH, Bethesda).

***Statistical analysis:*** Statistical analysis was performed using GraphPad Prism software version 5.04 (GraphPad Software, San Diego, CA). Statistical differences were assessed by one-way Analysis of variance (ANOVA) followed by Tukey\'s multiple comparison post-test. At least three independent triplicated experiments have been performed for each experimental set-up. For live cell fluorescence imaging, the number of experiments is indicated as "n = X/x" where X indicates the number of independent experiments and x indicates the total number of individual cells analyzed. Mean values for individual experiments are expressed as mean ± SEM, and P \< 0.05 was defined as statistically significant, indicated as \*; *p* \< 0.01 as \*\*; and *p* \< 0.001 as \*\*\*.

3. Results {#sec3}
==========

3.1. Quantitation of intracellular H~2~O~2~ by differentially-targeted biosensors {#sec3.1}
---------------------------------------------------------------------------------

For the quantification of intracellular H~2~O~2~ dynamics, we used the recently developed "ultrasensitive" ratiometric H~2~O~2~ biosensor, HyPer7.2 \[[@bib18]\]. Here we investigated H~2~O~2~ responses in the human vascular endothelial cell line EA.hy926, which has been extensively studied as a robust and informative model system for study of H~2~O~2~ signaling to eNOS \[[@bib4],[@bib17]\]. We created a fusion protein between HyPer7.2 and the chemogenetic H~2~O~2~-generating enzyme DAAO in order to simultaneously generate (DAAO) and detect (HyPer7.2) H~2~O~2~ in transfected cells \[[@bib14],[@bib18]\]. We used a signal sequence to direct the recombinant HyPer7.2-DAAO protein to the cell cytosol using a nucleus-exclusion signal sequence (NES, Cyto), as we did previously \[[@bib4]\]. We analyzed EA.hy926 cells transfected with the HyPer7.2-DAAO fusion construct in live cell imaging experiments to compare the biosensor responses to the addition of "physiological" levels of exogenous H~2~O~2~ (25 μM) with the biosensor responses to intracellular H~2~O~2~ generated by DAAO following addition of [d]{.smallcaps}-alanine (10 mM). As shown in [Fig. 1](#fig1){ref-type="fig"}, we found that both 10 mM [d]{.smallcaps}-alanine and 25 μM H~2~O~2~ promoted increases in cytosolic H~2~O~2~, as detected by HyPer7.2. The addition of exogenous H~2~O~2~ promoted a rapid increase in the HyPer7.2 ratiometric signal, which then decayed; the subsequent addition of [d]{.smallcaps}-alanine promoted no further increase in the HyPer7.2 signal. In contrast, the HyPer7.2 response following addition of [d]{.smallcaps}-alanine was slower; after the signal reached steady state, the addition of H~2~O~2~ led to a slight but significant increase in the HyPer7.2 ratio ([Fig. 1](#fig1){ref-type="fig"}B). The specificity of DAAO for [d]{.smallcaps}-alanine was confirmed by studying the HyPer7.2 response to [l]{.smallcaps}-alanine, which did not lead to any H~2~O~2~ formation ([Fig. 1](#fig1){ref-type="fig"}C) as we have previously shown \[[@bib19]\]. We confirmed that the cells that were unresponsive to [l]{.smallcaps}-alanine still had a robust HyPer7.2 response to exogenous H~2~O~2~ ([Fig. 1](#fig1){ref-type="fig"}C).Fig. 1**Sequential ratiometric responses of the cytosol-targeted chimeric biosensor HyPer7.2-DAAO:** Representative curves of ratiometric live-cell H~2~O~2~ imaging in EA.hy926 cells transfected with the cytosol-targeted biosensor/chemogenetic construct HyPer7.2-DAAO-NES, analyzed in real time in response to the sequential addition of (**A**) 25 μM H~2~O~2~ followed by 10 mM [d]{.smallcaps}-alanine, (**B**) [d]{.smallcaps}-alanine followed by H~2~O~2~ or (**C**) [l]{.smallcaps}-alanine (10 mM) followed by H~2~O~2~. Arrows indicate the times of drug addition. These experiments were independently repeated three times with similar results.Fig. 1

Given these differences in the response of cytosolic HyPer7.2 to exogenously added H~2~O~2~ versus DAAO-generated intracellular H~2~O~2~, we decided to characterize the H~2~O~2~ responses of differentially-targeted HyPer7.2-DAAO. We generated HyPer7.2-DAAO constructs targeted to the cell nucleus (Nuc), as we previously described for HyPer1 \[[@bib14]\]. We also used a targeting sequence to direct the HyPer7.2-DAAO fusion protein to plasmalemmal caveolae (Cav), which are signal-transducing membrane microdomains in endothelial cells \[[@bib17]\]. We then used cell imaging to analyze the H~2~O~2~ responses of HyPer7.2-DAAO targeted to the cytosol, nucleus or caveolae, once again comparing the HyPer7.2 response to extracellular vs. intracellular H~2~O~2~ in real time in EA.hy926 cells. For all three differentially-targeted biosensor constructs, we observed similarly rapid HyPer7.2 kinetics upon addition of H~2~O~2~ to the cells ([Fig. 2](#fig2){ref-type="fig"}A--C). Likewise, the response to [d]{.smallcaps}-alanine was similar in cytosol, nucleus, and caveolae, and in all cases was slower and of slightly lower magnitude than the response to extracellular H~2~O~2~. The addition of exogenous H~2~O~2~ leads to a faster but more transient increase in intracellular H~2~O~2~ compared to the response to [d]{.smallcaps}-alanine ([Fig. 2](#fig2){ref-type="fig"}D and E), whereas the response to H~2~O~2~ endogenously generated by DAAO is more sustained ([Fig. 2](#fig2){ref-type="fig"}A-C).Fig. 2**Simultaneous generation and detection of intracellular H**~**2**~**O**~**2**~**in different subcellular locales using differentially-targeted HyPer7.2-DAAO**. (**A-C**) Average curves HyPer7.2 ratio measured in response to 25 μM H~2~O~2~ (black curves) or 10 mM [d]{.smallcaps}-alanine (red curves) of EA.hy926 expressing HyPer7.2-DAAO in (**A**) cell cytosol (Cyto), (**B**) nucleus (Nuc) or (**C**) plasmalemmal caveolae (Cav). (**D**) Zoom in overlaid average curves presented in A-C after calculation of maximum responses of all individual cells treated with either H~2~O~2~ or [d]{.smallcaps}-Alanine defined as 100%. Time point 0 indicates time of application. (**E**) Statistical evaluation of average slopes expressed in %/s within the 10--70% interval of maximum cell responses to extracellular H~2~O~2~ or endogenously generated H~2~O~2~ by DAAO after adding [d]{.smallcaps}-alanine, in the cytosol (white bar, n = 8/18 and gray bar, n = 8/12); nucleus (white bar, n = 8/14 and gray bar, n = 9/21); or caveolae (white bar, n = 9/23 and gray bar, n = 8/18). (**F**) Columns represent maximal responses after application of exogenous H~2~O~2~ (white bars) vs. [d]{.smallcaps}-alanine (gray bars) of same cells and subcellular locales analyzed in E. All values are presented as mean ± S.D; *\*\*P \< 0.01*, *\*\*\*P \< 0.001.* Responses to [d]{.smallcaps}-Alanine vs. extracellular H~2~O~2~ application was analyzed by one-way ANOVA and Tukey\'s multiple comparison test. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)Fig. 2Fig. 3**Representative images of localized HyPer-DAAO expression.** The upper panels show representative widefield ratiometric HyPer images of EA.hy926 endothelial cells transduced with adenoviral AV5 vectors encoding HyPer-DAAO constructs targeted to (**A**) the cell cytosol (HyPerDAAO-NES); (**B**) the cell nucleus (HyPerDAAO-NLS) and (**C**) plasmalemmal caveolae (HyPerDAAO-Cav). The lower panels (**D**--**F**) show representative HyPer responses quantitated in real time after treatment with H~2~O~2~ (25 μM, black lines) or [d]{.smallcaps}-alanine (10 mM, red curves) of EA.926hy cells transduced with recombinant AV5 constructs expressing HyPer1-DAAO in different subcellular regions, as indicated. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)Fig. 3

3.2. Differential eNOS phosphorylation responses to intracellular and extracellular H~2~O~2~ {#sec3.2}
--------------------------------------------------------------------------------------------

The cell imaging analyses shown in [Fig. 1](#fig1){ref-type="fig"}, [Fig. 2](#fig2){ref-type="fig"} were performed using plasmid-based transfection methods; the low plasmid transfection efficiency of these endothelial cells does not preclude analyses in cell imaging approaches. But the study of biochemical responses to chemogenetically-generated H~2~O~2~ in these cells required more uniform expression of the recombinant proteins, and we decided to use viral transduction with adenovirus-5 (AV5). We generated chimeric AV5 constructs consisting of DAAO fused to the H~2~O~2~ biosensor HyPer1 targeted to the cytosol, the nucleus, or the caveolae, as was done in [Fig. 2](#fig2){ref-type="fig"}; the same DAAO cDNA was used for both plasmid- and adenovirus-mediated studies. We imaged the HyPer signals 48 h following transduction of EA.hy926 cells with recombinant AV5 constructs, and verified a robust and uniform level of expression of differentially-targeted HyPer-DAAO to the correct subcellular compartment ([Fig. 3](#fig3){ref-type="fig"}A--C). We also observed similar temporal patterns of HyPer responses following addition of either H~2~O~2~ or to [d]{.smallcaps}-alanine to these adenovirus-transduced cells ([Fig. 3](#fig3){ref-type="fig"}D--F). These findings set the stage for biochemical analyses of signaling responses in adenovirus-transduced EA.hy926 endothelial cells.

We observed strikingly different phosphorylation responses to exogenous vs. endogenous H~2~O~2~ ([Fig. 3](#fig3){ref-type="fig"}, [Fig. 4](#fig4){ref-type="fig"}, [Fig. 5](#fig5){ref-type="fig"}), in contrast to the similar maximal levels of intracellular H~2~O~2~ that were detected in response to exogenous H~2~O~2~ treatment and to chemogenetic generation of intracellular H~2~O~2~ ([Fig. 1](#fig1){ref-type="fig"}, [Fig. 2](#fig2){ref-type="fig"}). We focused first on studies of the endothelial signaling protein eNOS, a key caveolae-targeted phosphoprotein that undergoes H~2~O~2~-modulated phosphorylation at multiple sites \[[@bib11]\], and which also undergoes dynamic intracellular translocation following agonist activation \[[@bib8]\]. We transduced EA.hy926 endothelial cells with the three differentially-targeted AV5-HyPer-DAAO constructs, and then performed cell treatments either with [d]{.smallcaps}-alanine or with H~2~O~2~. We then probed immunoblots using well-characterized phosphospecific antibodies for eNOS and observed strikingly different phosphorylation responses to exogenous vs. by endogenous H~2~O~2~. As shown in [Fig. 4](#fig4){ref-type="fig"}, chemogenetic generation of H~2~O~2~ in either the cell cytosol (DAAO-NES), nucleus (DAAO-NLS), or caveolae (DAAO-Cav) led to a robust increase in the phosphorylation of eNOS at Ser^1177^, Thr^495^ following addition of [d]{.smallcaps}-alanine to the cells, whereas eNOS Ser^114^ underwent dephosphorylation, as has been previously seen in response to agonist treatment of endothelial cells \[[@bib20], [@bib21], [@bib22]\]. In contrast to the robust eNOS phosphorylation responses to the generation of intracellular H~2~O~2~ by DAAO, the addition of exogenous H~2~O~2~ to the cells led only to a nominal phosphorylation response ([Fig. 4](#fig4){ref-type="fig"}D and E). Indeed, Ser^1177^ was the only eNOS phosphorylation site that underwent a significant if weak phosphorylation in response to extracellular H~2~O~2~ (25 μM). We also performed [d]{.smallcaps}-alanine and H~2~O~2~ dose response experiments analyzing eNOS phosphorylation at Ser^1177^, and again found a much more robust phosphorylation response to DAAO-generated H~2~O~2~ compared to the response to extracellular H~2~O~2~ ([Supplementary Fig. 1](#appsec1){ref-type="sec"}). Adenoviral infection has no effect on [d]{.smallcaps}-alanine- or H~2~O~2~-dependent phosphorylation responses in these cells. ([Supplementary Fig. 3](#appsec1){ref-type="sec"}). We also did immunoblot experiments in EA.hy926 cells expressing differentially-targeted DAAO following [l]{.smallcaps}-alanine (10 mM) treatment and probed eNOS phosphorylation at Ser^1177^ ([Fig. 1](#fig1){ref-type="fig"}); treatments with [l]{.smallcaps}-alanine did not elicit eNOS phosphorylation in any subcellular compartment or any time point ([Supplementary Fig. 2](#appsec1){ref-type="sec"}).Fig. 4**Differential eNOS phosphorylation responses to intracellular vs. extracellular H**~**2**~**O**~**2**~**.** (**A-D**) The upper row shows representative immunoblots of time course experiments in EA.hy926 endothelial cells transduced with differentially-targeted DAAO-cells were then treated with [d]{.smallcaps}-alanine (10 mM) or H~2~O~2~ (25 μM). Cells were harvested at the time points indicated, and cell lysates were resolved by SDS-PAGE and probed with phosphospecific antibodies directed against eNOS phosphorylation sites Ser^1177^, Ser^114^, and Thr^495^. The cell lysates were also probed for total eNOS as a loading control to confirm equal loading. (**E**) These graphs present pooled data from three independent times course phosphorylation experiments, each performed in triplicate, showing the quantitative analysis of the intensities corresponding to phospho-eNOS at Ser^1177^, Ser^114^, and Thr^495^ by chemiluminescence. In constrast to the robust phosphorylation responses to [d]{.smallcaps}-alanine, addition of extracellular H~2~O~2~ promoted eNOS phosphorylation at a single phosphorylation site at a single time point (Ser114), a finding of uncertain biological significance. All values are presented as mean ± S.D. *\*P \< 0.05*, *\*\*P \< 0.01*, *\*\*\*P \< 0.001* compared to control analyzed by one-way ANOVA and Tukey\'s multiple comparison test.Fig. 4Fig. 5**Differential Akt or AMPK phosphorylation in response to intracellular or extracellular H**~**2**~**O**~**2**~**.** (**A-C**) shows representative immunoblots of time course experiments in EA.hy926 cells expressing differentially-targeted DAAO, incubated with 10 mM [d]{.smallcaps}-alanine, or with 25 μM extracellular H~2~O~2~ (**D**) Cell lysates were probed with phosphospecific antibodies directed against phosphorylated protein kinases Akt at Ser^473^ and AMPK at Thr^172^. The lower panel (**E**) shows data from three independent experiments in triplicate represent the quantitative analysis of the intensities corresponding to phospho-Akt^Ser473^ and -AMPK^Thr172^ by chemiluminescence. The values are presented as mean ± S.D. *\*P \< 0.05*, *\*\*P \< 0.01*, *\*\*\*P \< 0.001* compared to control analyzed by one-way ANOVA and Tukey\'s multiple comparison test.Fig. 5

3.3. Differential kinase Akt and AMPK phosphorylation responses to intracellular and extracellular H~2~O~2~ {#sec3.3}
-----------------------------------------------------------------------------------------------------------

Multiple protein kinases have been found to be involved in H~2~O~2~-modulated eNOS phosphorylation \[[@bib11],[@bib12]\]. Two of the key eNOS kinases are kinase Akt and the AMP-activated protein kinase (AMPK) \[[@bib22],[@bib23]\]. These kinases are known to be activated in response to H~2~O~2~ in multiple cell types including endothelial cells, and undergo dynamic translocation inside cells \[[@bib24],[@bib25]\]. We again used a chemogenetic approach to generate H~2~O~2~ in EA.hy926 endothelial cells that had been transduced with differentially-targeted AV5-HyPer-DAAO constructs. After adding [d]{.smallcaps}-alanine or H~2~O~2~ to transduced cells, we analyzed immunoblots probed with phosphospecific antibodies for kinase Akt (phosphorylated at Ser^473^) and AMPK (Thr^172^). For each of the three differentially-targeted DAAO constructs, [d]{.smallcaps}-alanine treatment elicited a robust 30-40-fold increase in kinase Akt phosphorylation. [d]{.smallcaps}-alanine treatment also promoted phosphorylation of AMPK, but the response for each of the differentially-targeted DAAO was an order of magnitude less than that seen for kinase Akt phosphorylation ([Fig. 5A--](#fig5){ref-type="fig"}C and E). In marked contrast, addition of extracellular H~2~O~2~ elicited no phosphorylation response whatsoever for either kinase Akt nor AMPK ([Fig. 5](#fig5){ref-type="fig"}D and E). Thus, as we found for H~2~O~2~-promoted eNOS phosphorylation ([Fig. 4](#fig4){ref-type="fig"}), neither AMPK nor kinase Akt phosphorylation is affected by exogenous H~2~O~2~, in contrast to the striking phosphorylation responses seen following intracellular generation of H~2~O~2~ by DAAO expressed in different subcellular organelles.

3.4. Differential phosphorylation pathways activated by H~2~O~2~ in the cell nucleus {#sec3.4}
------------------------------------------------------------------------------------

We next used a series of small molecular protein kinase inhibitors in order to probe the pathways leading from H~2~O~2~ to eNOS phosphorylation. We used the well-characterized PI3-kinase inhibitor wortmannin to block kinase Akt phosphorylation, and used the AMPK inhibitor Compound C in order to probe the effects of AMPK on downstream phosphorylation responses. Again, we studied EA.hy926 endothelial cells that had been transduced with AV5-DAAO constructs targeted to cytosol, nucleus or caveolae. After briefly pre-incubating the transduced cells either with the PI3--K inhibitor wortmannin or the AMPK inhibitor Compound C, we added [d]{.smallcaps}-alanine, harvested the cells at various times, and then analyzed phosphorylation responses in immunoblots probed with a series of phosphospecific antibodies.

As shown in [Fig. 6](#fig6){ref-type="fig"}, wortmannin inhibited all of the phosphorylation responses elicited by [d]{.smallcaps}-alanine-dependent activation of DAAO, including eNOS phosphorylation at Ser^1177^ and Ser^633^, and also blocking kinase Akt and AMPK phosphorylation. The inhibitory effect of wortmannin was seen to be independent of the intracellular source of H~2~O~2~. But in contrast to the inhibitory effects of wortmannin, we found that the AMPK inhibitor Compound C entirely failed to block the effects of cytosol- or caveolae-generated H~2~O~2~ on phosphorylation responses for all of these proteins. We are confident that Compound C was effective under these conditions since phosphorylation of the AMPK substrate acetyl-CoA carboxylase (ACC) was completely blocked by Compound C. Importantly, we found that the effects of Compound C on phosphorylation pathways activated by H~2~O~2~ generated in the cell nucleus were quite different than was observed for cytosol- or caveolae-generated H~2~O~2~. When H~2~O~2~ was generated by the nuclear-targeted DAAO, Compound C completely abrogated eNOS phosphorylation at Ser^1177^ and Ser^633^, and also blocked ACC phosphorylation--while yet leaving kinase Akt phosphorylation unaffected ([Fig. 6](#fig6){ref-type="fig"}).Fig. 6**Effects of kinase inhibitors on eNOS phosphorylation following H**~**2**~**O**~**2**~**generation by differentially-targeted DAAO.** Panels (**A-C**) show immunoblots represent the differential effects of PI3--K inhibitor, wortmannin or AMPK inhibitor, Compound C on cytosolic vs. nuclear vs. caveolar H~2~O~2~-mediated eNOS phosphorylation at stimulatory sites of Ser^1177^ and Ser^633^, as well as protein kinase AMPK Thr^172^ and its downstream acetyl-CoA carboxylase (ACC). The differentially-targeted DAAO-expressing EA.hy926 endothelial cells were individually pretreated with either wortmannin (1 μM) or Compound C (20 μM) for 30 min followed by incubation with [d]{.smallcaps}-alanine or [l]{.smallcaps}-alanine (10 mM) for 15 min. Cell lysates were probed with the phosphospecific antibodies directed against phosphorylation sites of eNOS at Ser1177 and Ser633, as well as AMPK at Thr172 and ACC at Ser79. Equal loading was confirmed by immunoblotting with antibodies directed against total eNOS, AMPK and ACC. (**D**) Shown are the pooled data analyzing the intensities corresponding to phospho-eNOS at Ser1177 and Ser633 plus phospho-AMPK at Thr172 and phospho-ACC by chemiluminescence from the independent experiments which were performed in triplicate at the same time. The values are presented as mean ± S.D. *\*P \< 0.05*, *\*\*P \< 0.01*, *\*\*\*P \< 0.001* compared to wortmannin- or Compound C-pretreated group analyzed by one-way ANOVA and Tukey\'s multiple comparison test.Fig. 6

4. Discussion {#sec4}
=============

These studies have exploited chemogenetic approaches to probe H~2~O~2~-modulated signaling responses in cultured vascular endothelial EA.hy926 cells. Our findings raise important caveats about the interpretation of signal transduction experiments in which H~2~O~2~ is added directly to cells. The signaling responses following addition of H~2~O~2~ directly to cultured cells ("extracellular H~2~O~2~") are remarkably different from the responses seen following the intracellular chemogenetic generation of H~2~O~2~. We found that the key endothelial signaling phosphoproteins Akt, AMPK, and eNOS exhibit robust and rapid phosphorylation responses following the chemogenetic generation of intracellular H~2~O~2~ by adding [d]{.smallcaps}-alanine to cells transfected with DAAO. In striking contrast, the effects of extracellular H~2~O~2~-- added at "physiological" concentration (25 μM) -- had a modest to nil effect on these phosphoproteins. Our data suggest that the protein phosphorylation responses promoted by either exogenous or endogenous H~2~O~2~ may depend more on the divergent kinetics and reactivity of localized intracellular H~2~O~2~ than on the absolute amount of H~2~O~2~. This disparity is reminiscent of findings made 40 years ago in the early years of studying cyclic AMP second messenger signal transduction \[[@bib26],[@bib27]\]. Back in the day, many papers analyzed cellular signaling responses after adding high concentrations of cyclic AMP to cultured cells. Only with later study did it become clear that the cellular responses that are elicited by treatments with extracellular cyclic AMP are strikingly different (and usually much less robust) that the responses seen following intracellular cyclic AMP generation in response to receptor-dependent activation of adenylate cyclase. There are important parallels between these observations in cyclic AMP- and H~2~O~2~-mediated signal transduction, and our current studies raise important concerns about the many hundreds of reports (including our own \[[@bib28],[@bib29]\]) that have relied upon analyses of cellular responses to extracellular oxidants \[[@bib7]\]. The current findings provide evidence that studies of signaling responses to extracellular H~2~O~2~ should be interpreted with caution.

Despite the markedly divergent signaling responses to extracellular vs. intracellular H~2~O~2~, the maximal levels of H~2~O~2~ measured in different subcellular locales were more similar than different. We expressed differentially-targeted fusion proteins between the yeast enzyme DAAO and the H~2~O~2~ biosensor HyPer, a chimeric protein that generates and detects H~2~O~2~ at levels found in mammalian cells \[[@bib30]\]. These fusion proteins were directed to specific subcellular locales using signal sequences in order to generate (DAAO) and detect (HyPer) H~2~O~2~ either in the cell cytosol, nucleus, or caveolae, and we then quantitated intracellular levels of H~2~O~2~ in real time using fluorescence microscopy. Extracellular H~2~O~2~ led to an increase in the HyPer ratio within 1--2 min; a similar time course was found whether H~2~O~2~ was quantitated in the cell cytosol, nucleus, or caveolae following addition of H~2~O~2~ to the cell culture media. These observations are consistent with there being similar rates of intracellular transport of H~2~O~2~ once it crosses the plasma membrane after being added to cultured cells \[[@bib15]\]. The time course of intracellular H~2~O~2~ detection following [d]{.smallcaps}-alanine addition to cells was slower than the response to extracellular H~2~O~2~, presumably reflecting both the time required for transport of [d]{.smallcaps}-alanine across the cell membrane and for its intracellular diffusion to reach the differentially-targeted DAAO constructs, as well as the time required for generation of H~2~O~2~ by the enzyme once its [d]{.smallcaps}-alanine substrate arrives (along with the enzyme\'s co-substrates). By contrast, the detection of exogenous H~2~O~2~ by HyPer is limited only by the intracellular diffusion/transport of H~2~O~2~ to the biosensor, which is then rapidly oxidized \[[@bib18]\]. Despite the disparate factors affecting H~2~O~2~ vs. [d]{.smallcaps}-alanine transport, diffusion, and metabolism-- as well as the complexities of DAAO catalysis-- we found that the HyPer response patterns were similar in different subcellular locales no matter whether H~2~O~2~ was added to cells extracellularly or generated within the cell by DAAO targeted to the cytosol, nucleus, or caveolae. Yet the consequences for cell signaling were strikingly divergent.

These studies have shown that the chemogenetic intracellular generation of H~2~O~2~-- whether from the cell cytosol, nucleus, or caveolae promotes quantitatively similar phosphorylation responses for kinase Akt, AMPK and for multiple different phosphorylation sites on eNOS. Yet we still hypothesized that H~2~O~2~ formed in different subcellular locales might activate distinct downstream signaling pathways on the way to promote the phosphorylation of eNOS. Following on our studies of kinase Akt and AMPK in eNOS phosphorylation ([Fig. 4](#fig4){ref-type="fig"}, [Fig. 5](#fig5){ref-type="fig"}), we decided to use small molecule inhibitors of these two kinases to try and dissect the intracellular phosphorylation pathways connecting intracellular H~2~O~2~ generation and eNOS. We found that the PI3--K/Akt inhibitor wortmannin blocked the entirety of all of the phosphorylation responses that were seen following activation of H~2~O~2~ produced by [d]{.smallcaps}-alanine in transduced cells. Whether the H~2~O~2~ was generated in the cell cytosol, nucleus, or caveolae, wortmannin completely abrogated the phosphorylation of eNOS, kinase Akt, and AMPK, as well as blocking the phosphorylation of the well-characterized AMPK substrate acetyl-CoA carboxylase (ACC). This finding establishes PI3--K/Akt as proximal determinant of H~2~O~2~-dependent phosphorylation responses in these cells. By contrast, the AMPK inhibitor Compound C inhibited phosphorylation responses *only* to nucleus-derived H~2~O~2~, and had no effect whatsoever on the phosphorylation response to caveolae- or cytosol-derived H~2~O~2~. Like other small molecule protein kinase inhibitors, Compound C is not absolutely specific for AMPK inhibition in all cells, but Compound C appears to be a highly selective AMPK inhibitor in endothelial cells \[[@bib31],[@bib32]\]. We are confident that the added Compound C was effective in blocking AMPK activity because phosphorylation of the AMPK substrate acetyl-CoA carboxylase (ACC) was completely blocked. Thus, AMPK does not appear to modulate eNOS phosphorylation in response to the generation of H~2~O~2~ in cytosol or caveolae, yet AMPK is essential for eNOS phosphorylation in response to H~2~O~2~ that is generated in the cell nucleus ([Fig. 6](#fig6){ref-type="fig"}, [Fig. 7](#fig7){ref-type="fig"}). Since AMPK is dynamically targeted to the cell nucleus \[[@bib23]\], these observations may identify a new target for AMPK-dependent signaling in response to oxidants in the cell nucleus.Fig. 7**Schematic model for eNOS phosphorylation pathways via differentially-targeted H**~**2**~**O**~**2**~**.** This ﬁgure presents a model showing pathways for modulation of eNOS phosphorylation pathways by H~2~O~2~ generated in different subcellular compartments (cytosol vs. nucleus vs. caveolae) in endothelial cells. We propose that H~2~O~2~ generated in the endothelial cell nucleus, but not in the cytosol or caveolae, leads to eNOS phosphorylation via AMPK. Extracellular H~2~O~2~ has only a nominal effect on these phosphorylation pathways. See text for details.Fig. 7

Our observations indicate that endothelial signaling pathways are differentially modulated by H~2~O~2~ generated in different subcellular locales. A critical question unanswered by these studies is the identity of the specific enzymes and pathways that modulate intracellular H~2~O~2~ levels in distinct organelles. It has long been known that the metabolic pathways that modulate intracellular oxidants are differentially distributed within cells \[[@bib1]\], Much has been written about this topic, but our understanding remains incomplete (see reviews in Ref. \[[@bib2],[@bib5],[@bib6]\]). There are multiple intracellular sources of H~2~O~2~, including NADPH oxidase isoforms targeted to diverse intracellular organelles, the mitochondrial electron transport chain, and a broad range of oxidoreductases. The catabolism of H~2~O~2~ in endothelial cells is also complexly determined, and involves glutathione/glutathione reductases, thioredoxin/thioredoxin reductases, catalase, and peroxiredoxins. These enzymes have distinct catalytic properties and are differentially distributed in cellular organelles. The disparate pathways involved in the generation and catabolism of H~2~O~2~ lead to an inhomogeneous distribution of the redox potential in specific subcellular compartments, and to distinct patterns of protein oxidative modifications in disparate locales of endothelial cells. Regional differences in redox state have direct implications for the regulation of eNOS, which undergoes dynamic translocation to and from plasmalemmal caveolae \[[@bib8]\]. Chemogenetic approaches may allow us to better understand the role of subcellular localization of H~2~O~2~ in the regulation of endothelial signaling pathways both in health and disease states characterized by oxidative stress.
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Appendix ASupplementary data {#appsec1}
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The following is the Supplementary data to this article:Supplementary Fig. 1**Dose response for D-alanine and H**~**2**~**O**~**2**~**in HyPer-DAAO transduced EA.hy926 cells analyzed for eNOS phosphorylation at Ser**^**1177**^. This figure shows quantitative pooled data derived from immunoblots probed with eNOS Ser^1177^ antibodies in dose response experiments performed in HyPer-DAAO-transduced EA.hy926 cells following treatment of cells with D-alanine (panel A; n=6 independent experiments) or H~2~O~2~ (panel B; n=5 independent experiments) for 15 minutes. The values are presented as mean ± S.D. *\*P\<0.05*, *\*\*P\<0.01*, \*\*\**P\<0.001* compared to dose=0.Supplementary Fig. 1Supplementary Fig. 2**Time course for L-alanine in HyPer-DAAO-transduced EA.hy926 cells analyzed for eNOS phosphorylation at Ser**^**1177**^. This figure shows representative immunoblots of time course experiments in EA.hy926 endothelial cells transduced with differentially-targeted HyPer-DAAO and then treated with L-alanine (10 mM) for the times shown. These figures are representative of experiments that were independently repeated three times with equivalent results.Supplementary Fig. 2Supplementary Fig. 3**Differential eNOS or Akt phosphorylation responses to intracellular or extracellular H**~**2**~**O**~**2**~**in adenovirus 5-HyPer-DAAO-transduced EA.hy926 cells.** Panel (A) shows representative immunoblots of EA.hy926 cells transduced with adenovirus 5-HyPer-DAAO-NES and incubated with 25 μM H~2~O~2~ or with 10 mM D-alanine for the times indicated. Panel (B) shows pooled data from three independent experiments performed in triplicate, analyzing immunoblots probed with antibodies directed against phospho-eNOS at Ser^1177^ and phospho-Akt at Ser^473^. The values are presented as mean ± S.D. \*\*\* indicates P\<0.001 compared to control (time=0) analyzed by one-way ANOVA and Tukey's multiple comparison test.Supplementary Fig. 3
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